Portfolio company
Arsenal Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops programmable T-cell therapies to treat solid tumours and autoimmune diseases for patients with cancer and chronic illnesses.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ArsenalBio
The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.
Arsenal Biosciences, Inc. (ArsenalBio)
This deep-tech company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.
Modulari-T Biosciences
This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.
Autolus Therapeutics
This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
Orca Bio
This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.
Strand Therapeutics
This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.
Luminary Therapeutics
This biotechnology company develops cell therapies to treat patients with cancers and autoimmune diseases.